Target validation: the Parkinson disease perspective
Dis Model Mech
.
2010 May-Jun;3(5-6):259-62.
doi: 10.1242/dmm.004192.
Authors
David G Standaert
,
Talene A Yacoubian
PMID:
20427553
DOI:
10.1242/dmm.004192
No abstract available
Publication types
Editorial
MeSH terms
Animals
Caenorhabditis elegans / metabolism
Clinical Trials as Topic
Drug Discovery
Humans
Parkinson Disease / genetics
Parkinson Disease / therapy*
Reproducibility of Results
Validation Studies as Topic*